Acuta Capital Partners, LLC Teva Pharmaceutical Industries LTD Transaction History
Acuta Capital Partners, LLC
- $98.8 Million
- Q3 2024
A detailed history of Acuta Capital Partners, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Acuta Capital Partners, LLC holds 25,000 shares of TEVA stock, worth $410,750. This represents 0.07% of its overall portfolio holdings.
Number of Shares
25,000Holding current value
$410,750% of portfolio
0.07%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding TEVA
# of Institutions
624Shares Held
573MCall Options Held
19.6MPut Options Held
6.77M-
Black Rock Inc. New York, NY43MShares$706 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.2MShares$595 Million35.87% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L334.5MShares$568 Million5.5% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$474 Million3.32% of portfolio
-
Exor Capital LLP London, X026.5MShares$435 Million14.79% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18.2B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...